AVR 6.45% $12.22 anteris technologies ltd

Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-140

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 819 Posts.
    Now we know why Mr Patto didn't buy any shares on Market it explains allot he probably knew well before hand even at the last AGM webinar where he tried to sound enthusiastic about the HSV2 nice poker face he had going but at the end charts do not lie it exposes hidden agendas like I have seen weeks before in advance and I also said the VAX was a no go but while I was sounding like a down ramper people got in of fear of missing out imagine the ones that got in on the high 30's sitting on a loss they will try catch a falling knife if this breaks below 28c nice investment strategy indeed.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.